D. Food and . Administration, Guidance for industry: food-effect bioavailability and fed bioequivalence studies Available from http, 2002.

. Faculté-de-médecine-de-strasbourg, Pharmacologie Générale DCEM1, 2004.

C. Carcos, Les récepteurs nucléaires CAR et PXR contrôlent l'induction des cytochromes P450 par le phénobarbital, Médecine, Science, vol.18, pp.429-466, 2002.

M. Ortiz-de, Plenum publishing corporation, chapter

L. Guo, 129­136, consulté sur internet le 20 Mai, Acta Pharmacol Sin Feb, vol.25, issue.2 2, 2004.

&. Publié-par-appleton and . Lange, Metabolism of toxicants: phase II reactions p113, 1994.

. Principes-fondamentaux-de-gastro­entérologie, États pathologiques et démarches thérapeutiques Astra zeneca http://www.gastroresource.com/gitextbook, 6­3.htm 18. Thérapeutique médicale buccodentaire : moyens et méthodes Par Dominique Muster, p.160, 2004.

L. Kroon, Drug interactions with smoking, American Journal of Health-System Pharmacy, vol.64, issue.18, 2007.
DOI : 10.2146/ajhp060414

T. Vial and J. C. Evreux, Tabac et médicaments : des interactions à ne pas méconnaître, La revue du Praticien, vol.6, issue.185, pp.11-15, 1992.

S. Zevin and N. L. Benowitz, Drug Interactions with Tobacco Smoking, Clinical Pharmacokinetics, vol.36, issue.6, pp.36-425, 1999.
DOI : 10.2165/00003088-199936060-00004

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, pp.34-52, 2005.

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, pp.81-82, 2005.

B. Khan, T. Ahmed, S. Karim, T. Monif, N. Saha et al., Comparative effect of different types of food on the bioavailability of cefaclor extended release tablet, European Journal of Drug Metabolism and Pharmacokinetics, vol.58, issue.Suppl. 3
DOI : 10.1111/j.2042-7158.1985.tb05031.x

M. Borin, M. Driver, and K. Forbes, Effect of Timing of Food on Absorption of Cefpodoxime Proxetil, The Journal of Clinical Pharmacology, vol.34, issue.suppl 3
DOI : 10.1128/AAC.34.6.1210

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, pp.192-195, 2005.

P. Neuvonen, Interactions with the Absorption of Tetracyclines, Drugs, vol.11, issue.1, pp.45-54, 1976.
DOI : 10.2165/00003495-197611010-00004

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, 0197.

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique Edité en 2005 par ELSEVIER: p135 43. 123bio.net: Biologie et recherche: Les differentes classes d'antibiotiques http, 2009.

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, p.152, 2005.

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, p.155, 2005.

C. P. Page, M. J. Curtis, M. C. Sutter, B. B. Hoffman, and J. Michael, Walker Pharmacologie intégrée Traduit par, p.433, 1999.

G. Zhanel, M. Walters, A. Noreddin, L. Vercaigne, A. Wierzbowski et al., The Ketolides, Drugs, vol.3, issue.7, pp.1771-804, 2002.
DOI : 10.2165/00003495-200262120-00006

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, p.153, 2005.

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, p.155, 2005.

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, p.139, 2005.

P. Bégué, Jacques Astruc Pathologie infectieuse de l'enfant Publié par, p.48, 1999.

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique BAGER Flemming; HELMUTH Reiner Epidemiology of resistance to quinolones in Salmonella Veterinary research, 3­4 (196 p.) (28 ref.), pp. 285­290 59. 123bio.net: Biologie et recherche: Les differentes classes d'antibiotiques http, pp.164-58, 2001.

C. Gaudy and J. Buxeraud, Antibiotiques: pharmacologie et thérapeutique, Borgia M, pp.238-61, 2005.

C. Peloquin, . Namdar, M. Singleton, and D. Nix, Pharmacokinetics of isoniazid under fasting conditions with food and with antiacids, pp.703-710, 1999.

C. Peloquin, . Namdar, M. Singleton, and D. Nix, Pharmacokinetics of rifampicin under fasting conditions with food and with antiacids, pp.12-18, 1999.

C. Peloquin, A. Bulpitt, G. Jaresko, R. Jelliffe, and D. Nix, Pharmacokinetics of ethambutol under fasting conditions with food and with antiacids, Antimicrob Agents Chemother, vol.43, pp.568-572, 1999.

C. Peloquin, A. Bulpitt, G. Jaresko, R. Jelliffe, G. James et al., Pharmacokinetics of pyrazinamid under fasting conditions with food and with antiacids, Pharmacotherapy, vol.18, pp.1205-1211, 1998.

E. Blackwell and B. , Interactions of monoamine oxydase inhibitors, amines and foodstuffs, Adv Pharmacol chemother, vol.8, pp.185-349, 1970.

M. Hauser and H. Baier, Interactions of Isoniazid with Foods, Drug Intelligence & Clinical Pharmacy, vol.294, issue.7-8, pp.617-618, 1982.
DOI : 10.1002/9780470718957.ch17

C. Uragoda and S. Lodha, Histamine intoxication in a tuberculous patient after ingestion of cheese, Tubercle, vol.60, issue.1, pp.59-61, 1979.
DOI : 10.1016/0041-3879(79)90058-8

D. Muster and L. Ben, Slama Thérapeutique médicale buccodentaire moyens et méthodes: moyens et méthodes Publié par, p.161, 2004.

A. Hulin, A. M. Deguillaume, S. Bretagne, and Y. , BÉZIE Bon usage des antifongiques dans le traitement des candidoses et aspergilloses invasives, J Pharm Clin, vol.24, issue.3, pp.125-163, 2005.

A. Arida, M. Al­tabakha, and H. Hamoury, Improving the High Variable Bioavailability of Griseofulvin by SEDDS, CHEMICAL & PHARMACEUTICAL BULLETIN, vol.55, issue.12
DOI : 10.1248/cpb.55.1713

T. Marc and W. Gérard, Guide Pharmaco 5ième édition ; Editions Lamarre 2004 86 Dossier ­ Les trithérapies antirétrovirales David Germanaud http, 2008.

A. Collier, S. Crosby, D. Cummings, K. Opheim, and L. Corey, Pharmacokinetics of oral zidovudine in patients with aids when administrated with and without a high­fat meal, Recommandations du groupe d'experts Sous la direction du Professeur Patrick Yeni Chapitre 11 :Pharmacologie des antirétroviraux 88 Unadkat JD, pp.229-232, 1990.

J. Sahai, K. Gallicano, and G. Garber, The effect of a protein meal on zidovudine pharmacokinetics in HIV- infected patients., British Journal of Clinical Pharmacology, vol.21, issue.supp. 2A, pp.657-660, 1992.
DOI : 10.1111/j.1365-2125.1986.tb05202.x

J. Iangel, E. Hussey, and P. Mydlow, Pharmacokinetic of (GR 109714X) 3TC administred with or without food to HIV­infected patients, Inf Conf AIDS Abstract PoB, vol.8, issue.3008, p.88, 1992.

K. Moore, S. Shaw, and A. Laurent, Lamivudine/zidovudine as a combine formulation tablet: bioequivalence compared with lamivudine and zidovudine administrated concurrently and the effect of food on95, Ann Pharmacother, vol.27, pp.480-489, 1993.

M. Dudley, K. Graham, and S. Kaul, Pharmacokinetics of Stavudine in Patients with AIDS or AIDS-Related Complex, Journal of Infectious Diseases, vol.166, issue.3, pp.480-485, 19922.
DOI : 10.1093/infdis/166.3.480

S. Kaul, B. Christofalo, R. Raymond, M. Stewart, and C. Macleod, Effect of food on the bioavailability of stavudine in subjects with human immunodeficiency virus infection, Antimicrob Agents Chemother Drugs, vol.4255, pp.729-736, 1998.

S. Hebl, Drugs Facts and Comparisons. St. Louis, MO: Facts and Comparisons 2000 absorption, J Clin Pharmacol, vol.39, pp.593-605, 1999.

W. Shuy, C. Knupp, K. Pittman, L. Dunkle, and R. Barbhaiya, Food-induced reduction in bioavailability of didanosine, Clinical Pharmacology & Therapeutics, vol.50, issue.5/1, pp.503-507, 1991.
DOI : 10.1038/clpt.1991.175

B. Damle, J. Yan, and D. Behr, Effect of food on the oral bioavailability of didanosine from enapsulated enteric coated beads, J Clin Pharmacol, vol.42, pp.471-425, 2002.

C. Knupp, R. Milbrath, and R. Barbhaiya, Effect of Time of Food Administration on the Bioavailability of Didanosine From a Chewable Tablet Formulation, The Journal of Clinical Pharmacology, vol.7, issue.6, pp.568-573, 1993.
DOI : 10.1023/A:1015890516119

M. Dudley, K. Graham, and S. Kaul, Pharmacokinetics of Stavudine in Patients with AIDS or AIDS-Related Complex, Journal of Infectious Diseases, vol.166, issue.3, pp.480-485, 19922.
DOI : 10.1093/infdis/166.3.480

S. Kaul, B. Christofalo, R. Raymond, M. Stewart, and C. Macleod, Effect of food on the bioavailability of stavudine in subjects with human immunodeficiency virus infection, Antimicrob Agents Chemother Drugs, vol.4255, pp.729-736, 1998.

S. Hebl, Drugs Facts and Comparisons, 2000.

H. Pecora-fulco-patricia and A. Margaret, 102 Effect of tenofovir on didanosine absorption in patients with

G. Morse, M. Fischl, S. Cox, L. Thompson, A. Della­coletta et al., Effect of food on the steady­state Phamarcokinectics of delavirdine mesylate in HIV patients, Program Abstract, 35th Interscience Conference in Antimicrobial Agents and chemotherapeutics (ICAAC), 1995.

W. Freimuth, Delavirdine mesylate, a potent non nucleoside HIV­1 reverse transcriptase inhibitor, Antiviral Chemotheray, vol.4, pp.279-389, 1996.

. Sustiva, Antiretroviral agents and food interactions, Infect Med, vol.107, issue.873, pp.836-875, 1998.

. Antiviraux, Inhibiteurs de la protéase du VIH http, 2008.

K. Yeh, . Deutsh, and H. Haddix, Single dose pharmacokinetiks og indinavir and the effect of food, Antimicrob Agents Chemother, vol.42, pp.332-338, 1998.

A. Saah, G. Winchell, and M. Nessly, Pharmacokinetic profile and tolerability of indinavir­ ritonavir conbinations in healthy volunteers Saquinavir: a review of its pharmacology and clinical potential in the management of HIV infection, Antimicrob Agents Chemother Drugs, vol.4552, pp.93-112, 1996.

G. Muirhead, T. Sahw, and P. Williams, Phamacokinetics of HIV proteinase inhibitor, Ro 318959, after single and multiple oral doses in healthy volunteers, Br J Clin Pharmacol, vol.34, p.170, 1992.

H. Kupferschmidt, K. Fattinger, H. Ha, F. Follath, and S. Kranhenbuhl, Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man, British Journal of Clinical Pharmacology, vol.11, issue.4, pp.355-359, 1997.
DOI : 10.1038/clpt.1993.84

D. Demarles, C. Gillotin, and S. Bonaventure­paci, Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice, Antimicrobial Agents and Chemotherapy, vol.46, issue.5, pp.1589-1590, 2002.
DOI : 10.1128/AAC.46.5.1589-1590.2002

L. Gustavson, W. Lam, and R. Bertz, Assessment of the bioequivalence and food effects for liquid and soft elastic capsule co­formulation of ABT­378/ ritonavir (ABT­378/r) in healty subjects, Presented at the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, 2000.

E. Ommara, V. Mummareni, and D. Randall, BMS­232632: A summary of multiple dose pharmacokinetic, food effect and drug interaction studies in healty subjects, Presented at the Seventh Conference on Retroviruses and Opportunistic Infections. Available at website : www.retroconference.org, 2000.

M. Sociétés-correspondantes, P. Et-perspectives, F. Aubry, and . Parc, Comptes rendus de la troisième, p.2, 2003.

F. Effect, . Bioavailability, and . Chloroquine, RxMed:Pharmaceutical Information ­ MALARONE http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS­%20Monographs/CPS­ %20(General%20Monographs­%20M)/MALARONE.html 130 Pharmacokinetics of halofantrine in man:effects of food and size dose;BrPharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine, Eur J Clin PharmacolJ. clin. Pharmac.Clin Pharmacol Ther, vol.2372, issue.285, pp.271-273, 1982.

N. Castro, H. Jung, and R. Medina, Interaction between Grapefruit Juice and Praziquantel in Humans, Antimicrobial Agents and Chemotherapy, vol.46, issue.5, pp.1614-1616, 2002.
DOI : 10.1128/AAC.46.5.1614-1616.2002

C. Guzzo, C. Furtek, and A. Porras, Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects, Journal of Clinical Pharmacology, vol.42, issue.10, pp.1122-1133, 2002.
DOI : 10.1177/009127002401382731

J. Nagy, H. Schipper, and R. Koopmans, Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability., The American Journal of Tropical Medicine and Hygiene, vol.66, issue.3, pp.260-263, 2002.
DOI : 10.4269/ajtmh.2002.66.260

H. Lange, R. Eggers, and J. Bircher, Increased systemic availability of albendazole when taken with a fatty meal, European Journal of Clinical Pharmacology, vol.5, issue.3, pp.315-317, 1988.
DOI : 10.1007/BF00540964

. Le-nitazoxanide-dans-les-diarrhées-À-rotavirus, . Pharmacorama-http, A. Allemon, S. De-bruyn, and C. Gengler, Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses, Int J Clin Pharmacol Ther, vol.40, pp.213-233, 2002.

C. Br and . Pharmacol, Handbook of Drugs for Tropical Parasitic Infections Par Yakoub, pp.601-605, 1998.